HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers-Reference-Cited by-同舟云学术

HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers

Published:2016-03 Issue:3 Volume:11 Page:414-419
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Li Bob T.,Ross Dara S.,Aisner Dara L.,Chaft Jamie E.,Hsu Meier,Kako Severine L.,Kris Mark G.,Varella-Garcia Marileila,Arcila Maria E.

Funder

National Cancer Institute

Boehringer Ingelheim

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference15 articles.

1. Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas;Arcila;Clin Cancer Res,2012

2. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs;Kris;JAMA,2014

3. Comprehensive molecular profiling of lung adenocarcinoma;Nature,2014

4. HER2 status in non–small cell lung cancer: results from patient screening for enrollment to a phase II study of herceptin;Heinmoller;Clin Cancer Res,2003

5. Evaluation of HER-2/neu gene amplification and protein expression in non–small cell lung carcinomas;Hirsch;Br J Cancer,2002

Cited by 221 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the future: Innovative design strategies and emerging challenges in HER2-targeted tyrosine kinase inhibitors for cancer therapy;European Journal of Medicinal Chemistry;2024-10

2. A signal-seeking phase 2 study of Trastuzumab emtansine in tumours harbouring HER2 amplification or mutation;npj Precision Oncology;2024-09-09

3. 3D layered co-culture model enhances Trastuzumab Deruxtecan sensitivity and reveals the combined effect with G007-LK in HER2-positive non-small cell lung cancer;Biochemical and Biophysical Research Communications;2024-09

4. Evaluation of HER2 immunohistochemistry expression in non-standard solid tumors from a Single-Institution Prospective Cohort;Exploration of Targeted Anti-tumor Therapy;2024-08-22

5. The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future Directions;Cancers;2024-08-19